Physician profile
Edwin J Lee
NPI 1992817605
$6,702.13
in general payments reported to CMS, 2019-2025
19 companies · $832 in 2025
The $832 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $1,200 · 2021: $293 · 2022: $411 · 2023: $2,179 · 2024: $1,359 · 2025: $832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,577 · Travel and Lodging: $775 · Education: $18.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,576.51 |
| Travel and Lodging | $774.52 |
| Education | $18.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,763.21 | 2021-2025 | Inspire |
| Medtronic USA, INC. | $1,337.11 | 2019-2020 | |
| Medtronic, INC. | $1,333.95 | 2023-2024 | Propel, Stealthstation S8 Platform |
| Regeneron Healthcare Solutions, INC. | $490.53 | 2021-2024 | Dupixent |
| Integra Lifesciences Corporation | $380.34 | 2024-2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Aerin Medical INC. | $377.94 | 2019-2025 | |
| Genzyme Corporation | $227.58 | 2019-2025 | |
| Stryker Corporation | $173.60 | 2019-2024 | Xpress Loprofile |
| Cochlear Americas | $106.37 | 2025 | Baha, Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Acclarent, INC | $93.53 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $87.16 | 2023-2024 | Entyvio |
| Astrazeneca Pharmaceuticals LP | $84.05 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.79 | 2022-2023 | Xifaxan |
| Optinose US, INC. | $52.09 | 2019-2024 | |
| Intersect Ent, INC. | $44.55 | 2019-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $37.76 | 2025 | Nucala |
| Ethicon US, LLC | $22.53 | 2022 | |
| Celltrion USA INC. | $18.62 | 2024 | Zymfentra |
| Nestle Healthcare Nutrition INC. | $18.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.